Phyla

Phyla

Biotechnology Research

San Francisco, California 1,592 followers

Making benzoyl peroxide obsolete for acne.

About us

At Phyla, we use cutting edge microbiome research and bacteriophage technology to develop new approaches to acne and other chronic diseases, providing long-term solutions without side effects. We leverage the microbiome and tackle the root cause, bacterial overgrowth, without causing collateral damage. Our products are clinically proven to kill only the bad bacteria, improve acne, and recalibrate the microbiome for long-term skin health. Additionally, our bacteriophage platform presents capabilities that can tackle many other bacterial diseases.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
San Francisco, California
Type
Privately Held
Specialties
microbiology, microbiome, acne, skincare, probiotics, and cosmeceuticals

Locations

Employees at Phyla

Updates

Similar pages

Funding

Phyla 6 total rounds

Last Round

Series A

Investors

Shiseido
See more info on crunchbase